Related Experiment Videos
Variant ventricular tachycardia in desipramine toxicity
Southern Medical Journal
|October 1, 1981
Summary
Desipramine toxicity can cause a unique form of ventricular tachycardia with distinct features like group beating and QRS changes. Recognizing this variant ventricular tachycardia is crucial for appropriate treatment, differing from standard ventricular tachycardia management.
Area of Science:
- Cardiology
- Clinical Toxicology
- Pharmacology
Background:
- Desipramine, a tricyclic antidepressant, can cause cardiotoxicity at toxic doses.
- Ventricular tachycardia (VT) is a serious cardiac arrhythmia that can be life-threatening.
Observation:
- A case of variant ventricular tachycardia (VT) induced by desipramine toxicity is presented.
- The arrhythmia exhibited unusual characteristics including repetitive group beating.
- Progressive shortening of the R-R interval, QRS widening, and axis changes were noted.
Findings:
- The observed variant VT demonstrated progressive intraventricular conduction abnormalities.
- These findings highlight a distinct presentation of VT in the context of desipramine overdose.
- The specific ECG manifestations differentiate this variant from classic VT.
Implications:
- Early recognition of this desipramine-induced variant VT is critical for patient management.
- Therapeutic strategies for this variant VT may differ from those used for classic VT.
- Understanding these unique features can improve clinical outcomes in cases of tricyclic antidepressant toxicity.